Drug Profile
Research programme: lorazepam transmucosal spray - EastGate Biotech
Alternative Names: Lorazepam transmucosal oral spray - EastGate BiotechLatest Information Update: 29 Mar 2023
Price :
$50
*
At a glance
- Originator EastGate Acquisitions
- Developer EastGate Biotech
- Class Antiemetics; Anxiolytics; Benzodiazepinones; Hypnosedatives; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Seizures
Most Recent Events
- 29 Mar 2023 Discontinued - Preclinical for Seizures in Canada (Transmucosal)
- 29 Mar 2023 Discontinued - Preclinical for Seizures in USA (Transmucosal)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Seizures in Canada (Transmucosal, Spray)